Table 4 Maturation time, blood flow and patency rate during the follow-up period
Groups | Maturation Time -days | The maximum pump-controlled blood flow rate -ml/min | Primary Patency Rate | Secondary Patency Rate | ||||
|---|---|---|---|---|---|---|---|---|
3 months | 6 months | 9 months | 3 months | 6 months | 9 months | |||
PTA group (n = 25) | 19.36 ± 13.94 | 232.60 ± 16.72 | 21/25 (84.0%) | 17/25 (68.0%) | 15/25 (60.0%) | 23/25 (92.0%) | 21/25 (84.0%) | 20/25 (80.0%) |
AVF reconstruction group (n = 19) | 58.63 ± 18.95 | 197.11 ± 10.45 | 17/19 (89.5%) | 14/19 (73.7%) | 13/19 (68.4%) | 19/19 (100%) | 18/19 (94.7%) | 18/19 (94.7%) |
t/ X²-Value | 7.926 | -8.116 | 0.274 | 0.168 | 0.331 | 1.592 | 1.236 | 1.991 |
p-Value | < 0.010 | < 0.010 | 0.60 | 0.68 | 0.57 | 0.21 | 0.27 | 0.16 |